Get notified of page updates

Cancer Treatment

Read about different genes that are linked to hereditary cancer, their associated risks and guidelines for screening, preventing and treating cancers in people with inherited mutations in these genes.

Stay up to date on research and information

Sign Up for FORCE Newsletters
Glossary on

Cancer Treatment for People with MAP

Currently there are no cancer treatments approved specifically for people with MAP. People with a MUTYH mutation who have been diagnosed with cancer may benefit from testing and may qualify for clinical trials looking for more effective treatments for cancer. Colorectal cancers in people with MAP often have an acquired mutation called KRAS G12C, and there are clinical trials investigating new medications to treat colorectal cancers with this specific KRAS mutation.

To learn more about standard of care treatment options for specific types of cancer, visit our section on Cancer Treatment by Cancer Type

Open Clinical Trials
Open Clinical Trials

The following studies are open to people with colorectal cancer with a KRAS G12C mutation. These mutations are particularly common in people with MAP. 

Last updated January 01, 2024